Purchase Order 75N91022P00900
Award Date
9/19/22
Potential Completion Date
9/18/24
Potential Value
$120K
Federal Agency
National Cancer Institute
Awardee
Dnanexus, Inc.
Ultimate Awardee
Not listed
NAICS Category
541519 - Other Computer Related Services
PSC Category
DA10 - It And Telecom - Business Application/Application Development Software As A Service
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Mountain View, CA 94040, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services National Institutes of Health National Human Genome Research Institute awarded a firm-fixed-price purchase order contract to Dnanexus, Inc. for a "Biobank Research Analysis Platform." The $12,569.50 contract does not have a set-aside designation and is for the delivery of cloud-based genomics data management and analysis services from Dnanexus, a for-profit organization. Through this award, Dnanexus will provide bioinformatics software,...
The National Cancer Institute (NCI) has awarded a $667,500.00 firm-fixed-price purchase order to Dnanexus, Inc. for a Platform as a Service (PaaS) solution to support the Confluence Project. The contract has a period of performance through September 8, 2027. Dnanexus is the sole provider of a commercially available cloud PaaS solution that meets the computational, security, and regulatory requirements necessary for this effort, including FedRAMP Moderate certification and compliance with...
This is a federal contract awarded by the Food and Drug Administration (FDA) to Dnanexus, Inc., a for-profit company providing cloud-based genomics data management and analysis services. The contract, titled "A Cloud Platform for Evaluating NGS-Based Diagnostic Test Pipelines," has a ceiling value of $1,993,255.79 and runs through April 27, 2018. The contract is a definitive contract with a firm fixed price pricing type. Dnanexus has previously held other federal contracts with the FDA...
This is a firm fixed price delivery order contract awarded by the Food and Drug Administration (FDA) to Dnanexus, Inc., a for-profit organization providing cloud-based genomics data management and analysis services. The $796,885.33 contract supports the FDA's PrecisionFDA program, which aims to advance regulatory science through precision medicine approaches. Dnanexus will provide cloud platform services, bioinformatics software, and database services to support the PrecisionFDA collaborative...
This is a $15,000,000.00 Other Transaction Agreement (OTA) awarded by the National Institutes of Health (NIH) to Dnanexus, Inc., a for-profit technology company headquartered in Mountain View, California. The contract, titled "ADAPT - ADVANCED ANALYSIS FOR PRECISION CANCER THERAPY TREATMENT AND ANALYSIS PLAN (TAP)," does not have a set-aside designation. The contract is focused on providing cloud-based genomics data management and analysis services to support precision medicine...
Dnanexus, Inc. was awarded a firm fixed price delivery order valued at one hundred ninety-four thousand five hundred ninety-eight dollars and thirteen cents ($194,598.13) by the Department of Health and Human Services' Food and Drug Administration (FDA). This delivery order, with a period of performance through September 2023 and no set-aside designation, is issued against Dnanexus' twenty million dollar ($20M) indefinite delivery contract for ongoing provision of the FDA's PrecisionFDA...
This is a firm fixed-price delivery order contract awarded to Dnanexus, Inc. by the Food and Drug Administration (FDA) to provide operations and maintenance support for the agency's PrecisionFDA platform. The $4,073,921.12 contract has a period of performance through September 29, 2024 and does not have a set-aside designation. Dnanexus is a for-profit company that specializes in cloud-based genomics data management and analysis services. Through prior federal contracts, Dnanexus has supported...
This firm-fixed-price delivery order for $631,840.53 was awarded by the Food and Drug Administration (FDA) to Dnanexus, Inc., a for-profit technology company specializing in cloud-based genomics data management and analysis services. The award is for Phase III of the FY24 Common Data Harmonization System, a project to develop and maintain cloud-based platforms that support collaboration between researchers and regulatory reviewers, as well as genomic data analysis environments. Dnanexus has...
This is a $1,051,402.26 firm-fixed-price definitive contract awarded by the Food and Drug Administration (FDA) to Dnanexus, Inc. for the development of a PRISM high-impact platform pilot to support pre-submission validation of electronic common technical documents (eCTDs) and sponsor-reviewer interaction. The contract has an ultimate completion date of September 9, 2025. Dnanexus is a for-profit cloud-based genomics data management and analysis services provider that has previously supported the...
Dnanexus, Inc. was awarded a $3,419,094.15 firm fixed price delivery order by the Department of Health and Human Services' Food and Drug Administration to provide continued development services for the agency's PrecisionFDA Increment D program. Under this delivery order issued against the company's existing $20 million small business set-aside indefinite delivery contract with the FDA for ongoing PrecisionFDA Collaborative Omics Environment support, Dnanexus will deliver operations, development,...